-

CLIA - Clinical Laboratory Improvement Amendments

Super Search Devices@FDA
510(k) | Registration & Listing | Adverse Events | Recalls | PMA | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA
 

New Search Back To Search Results
Test System NameEUROIMMUN ANCA IFA Granulocyte BIOCHIP Mosaic Test System  {Anti-PR3 and anti-MPO antigen dots} 
Document Number K083850
Analyte NameANTI-NEUTROPHIL CYTOPLASM ANTIBODIES (ANCA)
Analyte SpecialtyGeneral Immunology
ComplexityHIGH
Effective Date05/21/2009
Device Classification Name test system, antineutrophil cytoplasmic antibodies (anca)
510(k) NumberK083850
Device NameEUROIMMUN ANCA IFA EUROPLUS GRANULOCYTE BIOCHIP MOSAIC TEST SYSTEMS
Applicant
EUROIMMUN US INC
95 washington st
morristown,  NJ  07960
Contactkathryn kohl
Regulation Number866.5660
Classification Product Code
MOB  
Date Received12/24/2008
Decision Date 05/20/2009
Decision substantially equivalent - CLIA submission (CS)
Classification Advisory Committee Immunology
Review Advisory Committee Immunology
Statement/Summary/Purged Status Statement only
FDA Review Decision Summary
Type Traditional
Reviewed by Third Party No
Expedited Review No
 
-
-
-
-
-